Help Patients Maintain Continuity During ADHD Treatment
Specify DAW 1 on every prescription to help support ADHD treatment continuity and reduce pharmacy substitutions.
RELEXXII provides flexible methylphenidate dosing options, including 45 mg and 63 mg in-between strengths, to support ADHD medication titration and individualized treatment decisions.
Strengths listed for other brands are derived from ADHD Medication Guide dose conversions. Some products above may offer strengths that exceed 72 mg dose equivalents. All trademarks are the property of their respective owners. Source: adhdmedicationguide.com
Available in seven strengths, RELEXXII offers multiple methylphenidate dosing options to support individualized ADHD treatment and medication titration.
When transitioning to RELEXXII, guidance may help support the appropriate methylphenidate dose adjustment.
RELEXXII extended-release methylphenidate tablets should be taken orally once daily in the morning, with or without food.1
RELEXXII tablets must be swallowed whole with the aid of liquids and must not be chewed, divided, or crushed.1
Specify DAW 1 on every prescription to help support ADHD treatment continuity and reduce pharmacy substitutions.
Explore patient scenarios and considerations that may help guide personalized ADHD treatment decisions.
References: 1. RELEXXII package insert. Vertical Pharmaceuticals, LLC. 2. Data on file, Osmotica Pharmaceuticals.
All individuals depicted are models used for illustrative purposes only.
ADHD=attention deficit hyperactivity disorder